"Southwell's mission is to deliver a lifetime of quality and compassionate care for each patient we serve. We are with you for life, so we are building something remarkable through our hospitals and specialty clinics throughout South Georgia."

During the past decade, Tift Regional Health System Anita Stewart Oncology Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Tift Regional Health System Anita Stewart Oncology Center" are "Metastatic Breast Cancer" (1 trials) and "Soft Tissue Sarcoma" (1 trials). Many other conditions were trialed in "Tift Regional Health System Anita Stewart Oncology Center" in a lesser frequency.

Most popular intervention types in "Tift Regional Health System Anita Stewart Oncology Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (1 trials), "Fulvestrant" (1 trials), "Olaratumab" (1 trials) and "Standard Chemotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tift Regional Health System Anita Stewart Oncology Center" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Tift Regional Health System Anita Stewart Oncology Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Tift Regional Health System Anita Stewart Oncology Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Tift Regional Health System Anita Stewart Oncology Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".